|
Aug 21
|
Companies Like Vincerx Pharma (NASDAQ:VINC) Could Be Quite Risky
|
|
Jan 7
|
Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma
|
|
Dec 19
|
15 Best Falling Stocks To Buy Now
|
|
Dec 10
|
Vincerx Pharma Presents Preclinical VIP943 and VIP924 Posters at ASH 2023
|
|
Nov 2
|
Vincerx Pharma To Present Three Posters at ASH 2023 in December
|
|
Aug 10
|
Vincerx Pharma (NASDAQ:VINC) Will Have To Spend Its Cash Wisely
|
|
Aug 7
|
Vincerx Pharma Reports Second Quarter 2023 Financial Results and Provides Corporate Update
|